Shiseido has signed a binding agreement to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to an investor consortium led by Hong Kong-headquartered private equity firm IDG Capital, transferring the business that manufactures and sells the Aupres brand in China.
The Japanese cosmetics group said the transaction is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals that include clearances in China. Financial terms were not disclosed.
Ownership structure and assets
Under the agreement, funds managed by IDG Capital will take 95% of the equity through two special purpose vehicles, while a limited partnership enterprise set up mainly by SLC's incoming management team will hold the remaining 5%. The deal includes SLC's Beijing factory and production equipment.
SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group owned by the Beijing Municipal Government, and has sold the C-beauty brand Aupres since 1994. With the joint venture agreement due to expire in December 2026, the parties agreed not to renew it. On September 1, 2026, Shiseido acquired Beijing Liyuan's 35% stake, giving it full ownership ahead of the sale.
Strategic rationale and handover terms
Shiseido presents the divestment as part of its 2030 Medium-Term Strategy, which targets improved profitability and capital efficiency. The company said it intends to concentrate management resources on the areas where it holds what it calls its greatest competitive advantage, and to focus on priority brands and higher-growth opportunities. SLC, according to the group, is a business that needs continued investment in product innovation and digital capabilities.
Shiseido said China remains a strategically important market, describing it as attractive and dynamic, with a competitive landscape that keeps shifting as e-commerce expands, consumer behaviour changes and a broader set of market participants emerges.
To smooth the handover, Shiseido will license the intellectual property rights IDG needs to run the business. For a specified period after the transfer it will also provide support on new product development, technical assistance for the stable supply of existing products, and continued supply of raw materials and selected products. The company says these arrangements are meant to maintain the subsidiary's innovation capabilities, product quality and business continuity, and it expects independent operation under IDG to support SLC's sustainable growth and brand value.
Profit recovery in the background
The sale comes days after Shiseido reported a 124.3% year-on-year jump in core operating profit for the third quarter of 2026, to ¥67.5 billion (US$422.13 million). The group attributed the recovery to restructuring, cost reductions and improved margins rather than strong product demand, with like-for-like sales up 0.7%. On the strength of those results, Shiseido raised its full-year core operating profit forecast to ¥87 billion (US$546 million) from ¥59 billion (US$433 million).
